These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 28374979

  • 1. Matrix Metalloproteinase-2 Activity is Associated with Divergent Regulation of Calponin-1 in Conductance and Resistance Arteries in Hypertension-induced Early Vascular Dysfunction and Remodelling.
    Parente JM, Pereira CA, Oliveira-Paula GH, Tanus-Santos JE, Tostes RC, Castro MM.
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):246-256. PubMed ID: 28374979
    [Abstract] [Full Text] [Related]

  • 2. Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension.
    Blascke de Mello MM, Parente JM, Schulz R, Castro MM.
    Vascul Pharmacol; 2019 May; 116():36-44. PubMed ID: 30339939
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertension.
    Belo VA, Parente JM, Tanus-Santos JE, Castro MM.
    Biochem Pharmacol; 2016 Oct 15; 118():50-58. PubMed ID: 27531060
    [Abstract] [Full Text] [Related]

  • 4. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
    Castro MM, Rizzi E, Figueiredo-Lopes L, Fernandes K, Bendhack LM, Pitol DL, Gerlach RF, Tanus-Santos JE.
    Atherosclerosis; 2008 Jun 15; 198(2):320-31. PubMed ID: 18054360
    [Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinase-2 proteolysis of calponin-1 contributes to vascular hypocontractility in endotoxemic rats.
    Castro MM, Cena J, Cho WJ, Walsh MP, Schulz R.
    Arterioscler Thromb Vasc Biol; 2012 Mar 15; 32(3):662-8. PubMed ID: 22199370
    [Abstract] [Full Text] [Related]

  • 6. Sarcoplasmic reticulum calcium ATPase (SERCA) proteolysis by matrix metalloproteinase-2 contributes to vascular dysfunction in early hypertension.
    Blascke de Mello MM, Neves VGO, Parente JM, Pernomian L, de Oliveira IS, Pedersoli CA, Awata WMC, Tirapelli CR, Arantes EC, Tostes RCA, Schulz R, Castro MM.
    Eur J Pharmacol; 2024 Nov 15; 983():176981. PubMed ID: 39241943
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension.
    Pereira SC, Parente JM, Belo VA, Mendes AS, Gonzaga NA, do Vale GT, Ceron CS, Tanus-Santos JE, Tirapelli CR, Castro MM.
    Atherosclerosis; 2018 Mar 15; 270():146-153. PubMed ID: 29425960
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Changes in the vascular beta-adrenoceptor-activated signalling pathway in 2Kidney-1Clip hypertensive rats.
    Callera GE, Yeh E, Tostes RC, Caperuto LC, Carvalho CR, Bendhack LM.
    Br J Pharmacol; 2004 Apr 15; 141(7):1151-8. PubMed ID: 15006902
    [Abstract] [Full Text] [Related]

  • 11. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability.
    Castro MM, Rizzi E, Ceron CS, Guimaraes DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE.
    Nitric Oxide; 2012 Mar 31; 26(3):162-8. PubMed ID: 22327038
    [Abstract] [Full Text] [Related]

  • 12. Type I collagen proteolysis by matrix metalloproteinase-2 contributes to focal adhesion kinase activation and vascular smooth muscle cell proliferation in the aorta in early hypertension.
    de Oliveira Neves VG, Blascke de Mello MM, Rodrigues D, Pernomian L, de Oliveira IS, Parente JM, Arantes EC, Tostes RC, Castro MM.
    Vascul Pharmacol; 2023 Oct 31; 152():107211. PubMed ID: 37607602
    [Abstract] [Full Text] [Related]

  • 13. The Labdane Ent-3-Acetoxy-Labda-8(17), 13-Dien-15-Oic Decreases Blood Pressure In Hypertensive Rats.
    Simplicio JA, Simão MR, Ambrosio SR, Tirapelli CR.
    Arq Bras Cardiol; 2016 Jun 31; 106(6):481-90. PubMed ID: 27096521
    [Abstract] [Full Text] [Related]

  • 14. Morphological and functional alterations of mesenteric small resistance arteries in early renal hypertension in rats.
    Deng LY, Schiffrin EL.
    Am J Physiol; 1991 Oct 31; 261(4 Pt 2):H1171-7. PubMed ID: 1928399
    [Abstract] [Full Text] [Related]

  • 15. Decreased contraction to phenylephrine by ouabain in 2K-1C rat aorta is modulated by the endothelium.
    Molin JC, Sguilla FS, Bendhack LM.
    Eur J Pharmacol; 2005 Oct 17; 522(1-3):94-9. PubMed ID: 16188252
    [Abstract] [Full Text] [Related]

  • 16. Matrix Metalloproteinase 2 as a Potential Mediator of Vascular Smooth Muscle Cell Migration and Chronic Vascular Remodeling in Hypertension.
    Belo VA, Guimarães DA, Castro MM.
    J Vasc Res; 2015 Oct 17; 52(4):221-31. PubMed ID: 26731549
    [Abstract] [Full Text] [Related]

  • 17. Impaired relaxation to acetylcholine in 2K-1C hypertensive rat aortas involves changes in membrane hyperpolarization instead of an abnormal contribution of endothelial factors.
    Callera GE, Varanda WA, Bendhack LM.
    Gen Pharmacol; 2000 Jun 17; 34(6):379-89. PubMed ID: 11483287
    [Abstract] [Full Text] [Related]

  • 18. Progressive vascular remodelling, endothelial dysfunction and stiffness in mesenteric resistance arteries in a rodent model of chronic kidney disease.
    Quek KJ, Boyd R, Ameer OZ, Zangerl B, Butlin M, Murphy TV, Avolio AP, Phillips JK.
    Vascul Pharmacol; 2016 Jun 17; 81():42-52. PubMed ID: 26771067
    [Abstract] [Full Text] [Related]

  • 19. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.
    Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Shiva S, Tanus-Santos JE.
    Redox Biol; 2015 Dec 17; 6():386-395. PubMed ID: 26343345
    [Abstract] [Full Text] [Related]

  • 20. Smooth muscle dysfunction in resistance arteries of the staggerer mouse, a mutant of the nuclear receptor RORalpha.
    Besnard S, Bakouche J, Lemaigre-Dubreuil Y, Mariani J, Tedgui A, Henrion D.
    Circ Res; 2002 Apr 19; 90(7):820-5. PubMed ID: 11964376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.